711, 1976), adapted to a centrifugal analyzer. To separate the creatine kinase isoenzymes, 280 laboratories used 26 different methods or kits, including electrophoresis on cellulose acetate (45%) and agarose (39%), ion-exchange chromatography (13%), and selective activation (3%). Twenty-nine different methods or kits were used to quantitate the isoenzymes, with about 21 % of the laboratories using visual examination (ultraviolet irradiation). Quantitative values reported for the MB isoenzyme ranged from within normal limits to 19-fold greater for each sample. A few participants (14%) reported BB isoenzyme in every sample, although most laboratories indicated BB was absent. (9) (10) (11) ; kinetics (12) ; "high-performance" liquid chromatography (13, 14) ; and immunological (15) (16) (17) (18) (19) (20) and selective activation (21) . The importance of having sen-could be examined.
Although an interlaboratory study involving porcine-heart enzyme for determinationof totalCK activity has recently been reported (39) , we report on the use of stable, humansource CK samplessuitable for measurement of total CK activity and CK isoenzymes.
Materials and Methods

Materials2
Imidazole, hexokinase (EC 2.7. When five or more participants used the same method and temperature, the results were tabulated and are included in this report.
Results and Discussion
Total CK activity
Our mean values for total CK activity in the five pools are given in Table 1 . These data verify the expected relationship between predicted enzyme activity for each pool, based on the extent of dilution of Pool A.
To verify that vials from all pools were sufficiently uniform in CK content for distribution as samples in this study, we examined the vial-to-vial variation of each pool. The variability expressed as within-vial standard deviations in Table  1 represented total analytical errors, and the vial-to-vial variation indicated the degree of inter-vial homogeneity. For all pools except E (which contained the lowest CK activity) analytical errors were greater than variations among vials. Temperature-accelerated degradation experiments were performed on the lyophilized CK materials (Figure 1 ) to assure that the CK in the samples could withstand nationwide shipping to the participants and storage in their laboratories until they were assayed. Using the Arrhenius data derived from these studies (Figure 1 , inset) with the rate of degradation at high temperatures treated as first-order reactions, we have estimated that the half-life of the CK would be 2 to 7 years if the vials were stored at 37 #{176}C, and 1.5 X 10 years at -20 #{176}C. Therefore, the specimens were stable during the time required for this interlaboratory study. Table 2 for all method groups for which there were five or more laboratories.
Data from six laboratories were excluded on the basis of outlier exclusion (results greater than 3 SD from the original mean). The results obtained with the Scandinavian Society's Recommended Method (40) adapted to the GEM-SAEC are listed in Table 1 .
Because human myocardium was the source of the CK enzyme, artifacts seen with enzymes from nonhuman sources are not the cause of the analytical differences observed between groups of laboratories in Table 2 . Most method group results were apparently linear in response to increasing CK activity;
the differences between method group means resulted primarily from the different sulfhydryl activators and temperatures used for analysis.
Several other factors such as the formulation of reagents, instrumentation, calibration materials, and the omission of reagent blanks may disperse the data in Table 2 .
In some methods and reagent sets,thiolcompounds have been included in the reactionmixture to prevent inactivation of creatinekinase. Lost CK activity, however, is not only restored but actually enhanced (42) . The most potent activators (in kits or reagents), indicated by data in Table 3 are the means or medians and ranges of results whenever five or more participants using a particular method reported results as either a percentage or as CK activity. Table 4 contains data from participants who indicated the presence or absence of MB or BE isoenzyme in each sample by visual examination.
Participants were also asked whether the separation of the isoenzymes in their control materials and the CDC samples closely resembled that observed for fresh human sera; approximately 78% indicated that separation of their control material and of the CDC samples was similar to the separation of fresh human sera, seven laboratories indicated an increase CPK-lsoenzymes.Helena. electrophoresis, generally at 37 #{176}C.
CPK-CS (cardiac specific), Hoffmann-LaRoche. DEAE Sephadex. CPKrn,Worthington, DEAE Sephadex.
CK Isozyme, Corning. agarose electrophoresis. (In "Corning"rows,dashes are not quite aligned under 'UIL' columns.)
in background on electrophoresis plates, and six laboratories reported that migration rates for the CDC samples differed from those for fresh human sera. The quantitative isoenzyme results for MB and BB were expressed as a ratio of each participant's results (in either percentage of total CK activity or units of isoenzyme activity) to the upper limit of normal indicated by the participant.
To calculate a ratio for isoenzyme results for laboratories that indicated an upper limit of normal of zero, we assumed that the upper limit of normal was one (1).
Therefore, all ratios of 0 to 1 are within normal limits for the isoenzyme. The distributions of the calculated ratios are listed in Table 5 by the separation method for MB and RB isoenzymes for each sample. Because only human myocardium was used to prepare these samples, the amount of BB isoenzyme present should be negligible (43) . Most ratios for both qualitative and quantitative results support the conclusion that the BB isoenzyme was not present in any sample. Some laboratories using electrophoresis or ion-exchange chromatography separation techniques reported the presence of BB isoenzyme, but none of the laboratories using selective activation reported RB isoenzyme. The mode of sample preparation should have produced a constant proportion of MM and MB isoenzyme in every sample. Therefore, an increase in total CK activity should be reflected by a proportional increase in both MM and MB activity. The order of decreasing total CK activity was Pool A>B>C>D>E.
The same order should have been observed for MB activity for both qualitative and quantitative results.
Generally, the data presented in Tables 4 and 5 do followa pattern of decreasing MB activity from Pool A to Pool E. The order for MB activity, however, was not as sharply defined by users of electrophoresis as by users of ion-exchange chromatography or of selective activation techniques.
Ten laboratories that used electrophoretic separation reported results within normal limits for MB isoenzyme for both Pools A and B, whereas no participant using either ion-change chromatography or selected activation reported results within normal limits for both of these samples. None of the participants used an immunoassay for isoenzymes. Of those participants quantitating the isoenzymes, 69% used a reaction temperature of 37 #{176}C for the CK activity measurement; 13% used 30 #{176}C, 6.9% used room temperature;
5.0% each used 25 #{176}C or 32 #{176}C; and 2% used 37.5 #{176}C.
Participants were asked to provide the upper limit of their normal range for CK isoenzymes.
These limits were sorted according to the reaction temperature, and means and ranges were determined for both the MB and BB isoenzymes fractions (Table 6 ). Eight laboratories may have reported results as being within normal limits for MB isoenzyme activity for above-normal MB pools because of an inappropriately high value for the upper limit of normal for MB activity.
Most participants reported an increase in MB activity in Pools A, B, and C, a marginal increase in Pool D, and no increase in Pool E for both qualitative (Table 4 ) and quantitative results (Table 5 ). Most participants were in agreement that the RB isoenzyme was absent from all samples. Because After completing this study, we received a personal communication from Ying Foo and Sidney Rosalki of the Royal Free Hospital in London, England, in which they outlined their findings with the Merck inomunoinhibition technique. They concluded that, in contrast to patients' sera, the samples distributed in this study yielded different MB contents; that is, MB estimates by the immunoinhibition technique were higher than by a cellulose-acetate electrophoretic technique. They postulate that the lyophilized MM CK in these samples was abnormally resistant to immunoinhibition by anti-M antibody.
